Cargando…
Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro
SARS-CoV-2 rapidly infects millions of people worldwide since December 2019. There is still no effective treatment for the virus, resulting in the death of more than one million patients. Inhibiting the activity of SARS-CoV-2 main protease (Mpro), 3C-like protease (3CLP), is able to block the viral...
Autores principales: | Tam, Nguyen Minh, Nam, Pham Cam, Quang, Duong Tuan, Tung, Nguyen Thanh, Vu, Van V., Ngo, Son Tung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694027/ https://www.ncbi.nlm.nih.gov/pubmed/35424256 http://dx.doi.org/10.1039/d0ra09858b |
Ejemplares similares
-
Upgrading nirmatrelvir to inhibit SARS-CoV-2 Mpro via DeepFrag and free energy calculations
por: Tam, Nguyen Minh, et al.
Publicado: (2023) -
Potential inhibitors for SARS-CoV-2 Mpro from marine compounds
por: Tam, Nguyen Minh, et al.
Publicado: (2021) -
Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations
por: Tam, Nguyen Minh, et al.
Publicado: (2021) -
Unbinding ligands from SARS-CoV-2 Mpro via umbrella sampling simulations
por: Tam, Nguyen Minh, et al.
Publicado: (2022) -
Searching for potential inhibitors of SARS-COV-2 main protease using supervised learning and perturbation calculations
por: Nguyen, Trung Hai, et al.
Publicado: (2023)